
News|Articles|April 1, 2003
Xanax (alprazolam extended release)
Alprazolam, which was previously approved for the treatment of anxiety and panic disorder, has now received FDA approval as extended-release tablets for the treatment of panic disorder.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Payer Implications and Final Takeaways from the BE BOLD Trial
2
Medicare Part D redesign reshapes market
3
A conversation with Tiffany Phung, Pharm.D., CSP, about how patient outcomes drive specialty pharmacy strategy
4
The sleep doctor who lives with a disorder he treats
5
















